Open AccessInfluence of respiratory viruses on the evaluation of the 13-valent pneumococcal conjugate vaccine effectiveness in children under 5 years old: A time-series study for the 2001-2013 period
Author(s) -
Ángela Gentile,
María del Valle Juarez,
María Florencia Luciön,
Viviana Sandra Romanin,
Norberto Giglio,
Julia Bakin
Publication year - 2015
Publication title -
archivos argentinos de pediatría
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.236
H-Index - 19
eISSN - 1668-3501
pISSN - 0325-0075
DOI - 10.5546/aap.2015.eng.310
Subject(s) - pneumococcal conjugate vaccine , medicine , respiratory system , pediatrics , pneumococcal infections , series (stratigraphy) , streptococcus pneumoniae , conjugate vaccine , covid-19 , virology , immunology , immunization , biology , microbiology and biotechnology , antigen , antibiotics , paleontology , disease , infectious disease (medical specialty)
S treptococcus pneumoniae is the main agent in bacterial consolidated pneumonias. In 2012, the 13-valent pneumococcal conjugate vaccine was introduced in the Argentine national immunization schedule for immunocompetent children as of two months old with a two-dose schedule plus a booster.